BIGG

The use of lateral flow urine lipoarabinomannan assay (‎LF-LAM)‎ for the diagnosis and screening of active tuberculosis in people living with HIV: policy guidance

World Health Organization.

Tests based on the detection of mycobacterial lipoarabinomannan (LAM) antigen in urine have emerged as potential point-of-care tests for tuberculosis (TB). LAM antigen is a lipopolysaccharide present in mycobacterial cell walls, which is released from metabolically active or degenerating bacterial cells ...

Tuberculosis/diagnóstico, Infecciones por VIH/complicaciones, Pruebas Serológicas, Tuberculosis/orina

Texto completo

Consolidated guidelines on HIV testing services

World Health Organization.

The Consolidated guidelines on HIV testing services bring together existing guidance relevant to the provision of HIV testing services (HTS) and addresses issues and elements for effective delivery of HTS that are common in a variety of settings, contexts and diverse populations. In addition, this docume...

Serodiagnóstico del SIDA, Infecciones por VIH/diagnóstico, Consejo Dirigido, Promoción de la Salud, Pruebas Diagnósticas de Rutina, Consentimiento Informado, Confidencialidad

Texto completo (enlace principal) Texto completo (enlace alternativo) Texto completo (enlace alternativo) Texto completo (enlace alternativo)

Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV

World Health Organization.

This early-release guideline makes available two key recommendations that were developed during the revision process in 2015. First, antiretroviral therapy (ART) should be initiated in everyone living with HIV at any CD4 cell count. Second, the use of daily oral pre-exposure prophylaxis (PrEP) is recomme...

Profilaxis Pre-Exposición, Infecciones por VIH/prevención & control, Infecciones por VIH/tratamiento farmacológico, Antirretrovirales/uso terapéutico, Tiempo de Tratamiento

Texto completo (enlace principal) Texto completo (enlace alternativo)